FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

38375911000001109: Hydroxychloroquine 200mg tablets (Ipca Laboratories UK Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 13-May 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1320341000001110 Hydroxychloroquine 200mg tablets (Ipca Laboratories UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1320351000001113 Hydroxychloroquine 200mg tablets (Ipca Laboratories UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Hydroxychloroquine 200mg tablets (Ipca Laboratories UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Hydroxychloroquine 200mg tablets (Ipca Laboratories UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Hydroxychloroquine 200mg tablets (Ipca Laboratories UK Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Hydroxychloroquine 200mg tablets (Ipca Laboratories UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Hydroxychloroquine 200mg tablets (Ipca Laboratories UK Ltd) Is a Product containing precisely hydroxychloroquine sulfate 200 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Hydroxychloroquine 200mg tablets (Ipca Laboratories UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Hydroxychloroquine 200mg tablets (Ipca Laboratories UK Ltd) Has specific active ingredient Hydroxychloroquine sulfate true Inferred relationship Existential restriction modifier
Hydroxychloroquine 200mg tablets (Ipca Laboratories UK Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Hydroxychloroquine 200mg tablets (Ipca Laboratories UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Hydroxychloroquine 200mg tablets (Ipca Laboratories UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Hydroxychloroquine 200mg tablets (Ipca Laboratories UK Ltd) 60 tablet 6 x 10 tablets Has AMP True Hydroxychloroquine 200mg tablets (Ipca Laboratories UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start